Neuronetics Inc (STIM)
3.90
+0.07
(+1.83%)
USD |
NASDAQ |
Apr 19, 11:40
Neuronetics Cash from Investing (TTM): -1.322M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.322M |
September 30, 2023 | -1.262M |
June 30, 2023 | 7.946M |
March 31, 2023 | 7.622M |
December 31, 2022 | 6.731M |
September 30, 2022 | 6.433M |
June 30, 2022 | -10.77M |
March 31, 2022 | -10.24M |
December 31, 2021 | -9.839M |
September 30, 2021 | -9.153M |
June 30, 2021 | -1.354M |
March 31, 2021 | -1.139M |
December 31, 2020 | -0.73M |
Date | Value |
---|---|
September 30, 2020 | -0.974M |
June 30, 2020 | -0.899M |
March 31, 2020 | -0.805M |
December 31, 2019 | -0.813M |
September 30, 2019 | -0.815M |
June 30, 2019 | -0.896M |
March 31, 2019 | -0.988M |
December 31, 2018 | -1.011M |
September 30, 2018 | -0.925M |
June 30, 2018 | -0.955M |
March 31, 2018 | -0.807M |
December 31, 2017 | -0.594M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-10.77M
Minimum
Jun 2022
7.946M
Maximum
Jun 2023
-1.172M
Average
-0.899M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Delcath Systems Inc | -19.71M |
Star Equity Holdings Inc | 16.18M |
Exact Sciences Corp | 49.68M |
CytoSorbents Corp | -0.9362M |
Progyny Inc | -200.52M |